Related Experiment Video
Updated: Jul 6, 2026
09:55
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
Integrin scintimammography using a dedicated breast imaging, solid-state gamma-camera and (99m)Tc-labelled NC100692
Tore Bach-Gansmo1, Trond V Bogsrud, Arne Skretting
1Department of Nuclear Medicine, Institute for Surgical Sciences, University of Bergen, Bergen, Norway. ingolv.tore.bach-gansmo@helse-bergen.no
Clinical Physiology and Functional Imaging
|April 4, 2008
Summary
Integrin scintimammography using NC100629 and the LumaGEM gamma-camera effectively detected breast cancer in most patients. This combination shows high efficacy for breast cancer diagnosis.
Area of Science:
- Nuclear medicine
- Oncology
- Medical imaging
Background:
- Breast cancer diagnosis relies on imaging techniques.
- Integrin-targeted radiotracers offer potential for improved detection.
- Dedicated gamma-cameras may enhance imaging resolution.
Purpose of the Study:
- To evaluate the detection ability of integrin scintimammography with NC100629 and the LumaGEM gamma-camera for breast cancer.
- To assess the effectiveness of this novel imaging combination in a clinical setting.
Main Methods:
- Eight patients with suspected breast cancer underwent scintimammography.
- Patients received (99m)Tc-labelled NC100629.
- Imaging was performed using the LumaGEM gamma-camera with cranio-caudal and lateral views under moderate breast compression.
Main Results:
- The LumaGEM system identified 9 out of 11 breast malignancies, with sizes ranging from 6-20 mm.
- Two small lesions (one 2.5 mm) in patients with multicentric disease were missed.
- One case was inconclusive due to significant breast hypertrophy.
Conclusions:
- The combination of NC100629 and the LumaGEM gamma-camera demonstrated high effectiveness in diagnosing breast cancer.
- This approach shows promise for improving breast cancer detection rates.
